Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced Clinical trial data shows RAD 101 detects Brain Metastases Download the PDF here. This post appeared first on investingnews.com 0 Related Posts DFS Investor Webinar Presentation July 2, 2025 QEM Appoints Robert Cooper as Director, following Leadership Transition July 2, 2025 Blackstone Secures $22.6m for Mankayan Copper-Gold Drilling July 2, 2025